p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

Autor(en): Lebok, Patrick
Roming, Magdalena
Kluth, Martina
Koop, Christina
Özden, Cüneyt
Taskin, Berivan
Hussein, Khakan
Lebeau, Annette
Witzel, Isabell
Wölber, Linn
Geist, Stefan
Paluchowski, Peter
Wilke, Christian
Heilenkötter, Uwe
Müller, Volkmar
Schmalfeldt, Barbara
Simon, Ronald
Sauter, Guido
Terracciano, Luigi
Krech, Rainer
von der Assen, Albert
Burandt, Eike
Stichwörter: CDKN2A; Breast cancer; Medicine; Tissue microarray; Cancer; PTEN; Gynecology; Oncology; Pathology; Internal medicine; Biology; Genetics; PI3K/AKT/mTOR pathway; Apoptosis
Erscheinungsdatum: 2016
Volumen: 7
Ausgabe: 49
Startseite: 81322
Seitenende: 81331
DOI: https://doi.org/10.18632/oncotarget.13227

Show full item record

Page view(s)

1
Last Week
0
Last month
0
checked on May 18, 2024

Google ScholarTM

Check

Altmetric